-
平臺(tái)編號(hào)：bio-67404
-
國(guó)際編號(hào)：ATCC 39920
-
拉丁屬名： Streptococcus equi subsp. zooepidemicus
-
規(guī)格：freeze-dried
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
馬鏈球菌獸疫亞種
Streptococcus equi subsp. zooepidemicus Farrow and Collins 拉丁名
(ATCC 39920) 統(tǒng)一編號(hào)
Strain Designations 菌株別名 HA-116
Application 用途 Produces hyaluronic acid Production of high molecular weight hyaluronic acid
Isolation 分離基物 Nitrosoguanidine-induced mutant of clinical isolate HA-100
Type Strain 模式菌株 no
Biosafety Level 生物安全等級(jí) 2
Product Format 提供形式 freeze-dried
Storage Conditions 保藏條件
Frozen 冷凍物: -80℃ or colder
Freeze-Dried 凍干物: 2℃ to 8℃
Live Culture 活物: See Propagation Section
Preceptrol no
Type Strain 模式菌株 no
Medium 培養(yǎng)基 ATCC Medium 44: Brain Heart Infusion Agar/Broth
ATCC Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions 生長(zhǎng)條件
Temperature 培養(yǎng)溫度: 37℃
Atmosphere 需氧情況: Aerobic
Name of Depositor 寄存人 Biotechnology General Corp.
U.S. Patent Number 4,780,414
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Isolation Nitrosoguanidine-induced mutant of clinical isolate HA-100
References 參考文獻(xiàn) Nimrod A, et al. Method of producing high molecular weight sodium hyallronate by fermentation of Streptococcus. US Patent 4,780,414 dated Oct 25 1988 Nimrod A, et al. High molecular weight sodium hyaluronate. US Patent 4,784,990 dated Nov 15 1988
